SCHEMBL19081636

SCHEMBL19081636

c1ccc(-c2c3ccccc3c(-c3ccc4cc(-c5cc6c7cc8ccccc8cc7oc6c6oc7ccccc7c56)ccc4c3)c3ccccc23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.35
ESR2 Q92731 2/20 0.35
KDM4E B2RXH2 5/20 0.35
MAPT P10636 4/20 0.35
HSD17B10 Q99714 4/20 0.35
HPGD P15428 3/20 0.35
ALDH1A1 P00352 3/20 0.35
TSHR P16473 3/20 0.35
CASP7 P55210 2/20 0.35
ALOX15 P16050 1/20 0.35
CASP1 P29466 1/20 0.35
GPR84 Q9NQS5 2/20 0.34
ALOX5 P09917 2/20 0.34
KMT2A Q03164 3/20 0.33
MAPK1 P28482 1/20 0.33
ADORA2A P29274 1/20 0.33
CDC14B O60729 1/20 0.33
CDC14A Q9UNH5 1/20 0.33
L3MBTL1 Q9Y468 3/20 0.32
CYP1A2 P05177 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945331 0.93 ALOX5 (0.39) ESR1ESR2KDM4EMAPTHSD17B10
SCHEMBL19081431 0.90 ESR1 (0.38) ESR1ESR2KDM4EMAPTHSD17B10
SCHEMBL17932184 0.89 ALOX5 (0.40) ESR1ESR2KDM4EMAPTHSD17B10
SCHEMBL17944788 0.88 ALOX5 (0.40) KDM4EMAPTHSD17B10HPGDALDH1A1
SCHEMBL17945077 0.88 ALOX5 (0.36) ESR1ESR2KDM4EMAPTHSD17B10
SCHEMBL19081631 0.87 KDM4E (0.37) ESR1ESR2KDM4EMAPTHSD17B10
SCHEMBL17945581 0.84 PGR (0.37) ESR1ESR2KDM4EMAPTHSD17B10
SCHEMBL17944087 0.84 ALOX5 (0.37) ESR1ESR2KDM4EMAPTHSD17B10
SCHEMBL17945327 0.84 ALOX5 (0.40) ESR1ESR2KDM4EMAPTHSD17B10
SCHEMBL17944158 0.84 ALOX5 (0.37) ESR1ESR2KDM4EMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885KDM4E 3720/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885KDM4E 3720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.